<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01636193</url>
  </required_header>
  <id_info>
    <org_study_id>115926</org_study_id>
    <nct_id>NCT01636193</nct_id>
  </id_info>
  <brief_title>Drug Use Investigation for ROTARIX®</brief_title>
  <official_title>Drug Use Investigation for ROTARIX</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      This study aims to assess the safety of Oral Rotarix® under clinical practice; and collect
      information regarding typical symptoms of intussusceptions and bloody stool in Japan.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is non-interventional study conducted in one group received Oral Rotarix®. This
      surveillance is abbreviated as SMILER (Surveillance and Monitoring In Living clinical
      Experience for Rotarix).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of Adverse events under clinical practice.</measure>
    <time_frame>During the 31-day observation period after each vaccination.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of typical symptoms of intussusceptions and bloody stool.</measure>
    <time_frame>During the 31-day observation period after each vaccination.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1607</enrollment>
  <condition>Infections, Rotavirus</condition>
  <arm_group>
    <arm_group_label>Rota Group</arm_group_label>
    <description>Subjects will receive Rotarix® as per routine practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Oral Rotarix®</intervention_name>
    <description>2 doses administered orally.</description>
    <arm_group_label>Rota Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Safety data will be collected through the check of health observation diary and interview of vaccinee's parent.</description>
    <arm_group_label>Rota Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Infants who receive Rotarix for the first time to prevent rotavirus gastroenteritis as part
        of routine immunisation programme.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Infants who receive Rotarix for the first time to prevent rotavirus gastroenteritis, an
        indication of Rotarix, will be included in the investigation.

        Exclusion Criteria:

        • All infants included in the special drug use investigation of Oral Rotarix will be
        excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2012</study_first_submitted>
  <study_first_submitted_qc>July 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2012</study_first_posted>
  <last_update_submitted>August 13, 2015</last_update_submitted>
  <last_update_submitted_qc>August 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rotavirus</keyword>
  <keyword>Rotarix</keyword>
  <keyword>Drug Use Investigation</keyword>
  <keyword>Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

